Abstract
We have investigated the in vivo antitumor mechanism of natural human tumor necrosis factor (n‐TNF) isolated from a culture of human leukemic B cell line (BALL‐1), especially its action as an immunomodulator, and found that the in vivo antitumor effect of n‐TNF on Meth A sarcoma implanted in BALB/c mice pretreated with monoclonal antibody against T cell‐specific surface antigen (Thy‐1) was significantly diminished. Furthermore, when BALB/c mice were treated with T cell subset‐specific monoclonal antibodies, anti‐L3T4 or anti‐Lyt‐2.2, the antitumor effect of n‐TNF on Meth A sarcoma was significantly reduced. Therefore, it was suggested that the in vivo antitumor mechanism of n‐TNF might involve a T cell‐mediated immunological route.
Keywords: Tumor necrosis factor, In vivo antitumor mechanism, T cell subset, Monoclonal antibody
Full Text
The Full Text of this article is available as a PDF (219.2 KB).
REFERENCES
- 1. ) Carswell , E. A. , Old , L. J. , Kassel , R. L. , Green , S. , Fiore , N. and Williamson , B.An endotoxin‐induced serum factor that causes necrosis of tumors . Proc. Natl. Acad. Sci. USA , 72 , 3666 – 3670 ( 1975. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Creasey , A. A. , Reynolds , M. T. and Laird , W.Cures and partial regression of murine and human tumors by re‐combinant human tumor necrosis factor . Cancer Res. , 46 , 5687 – 5690 ( 1986. ). [PubMed] [Google Scholar]
- 3. ) Asher , A. , Mule , J. J. , Reichert , C. M. , Shiloni , E. and Rosenberg , S. A.Studies on the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo . J. Immunol. , 138 , 963 – 974 ( 1987. ). [PubMed] [Google Scholar]
- 4. ) Tomazic , V. J. , Farha , M. , Loftus , A , and Elias , E. G.Anti‐tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro . J. Immunol. , 140 , 4056 – 4061 ( 1988. ). [PubMed] [Google Scholar]
- 5. ) Haranaka , K. , Satomi , N. and Sakurai , A.Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice . Int. J. Cancer , 34 , 263 – 267 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Lattime , E. C. , Stoppacciaro , A. , Khan , A. and Stutman , O.Human natural cytotoxic activity mediated by tumor necrosis factor: regulation by interleukin‐2 . J, Natl Cancer Inst. , 80 , 1035 – 1038 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Owen‐Schaub , L. B. , Gutterman , J. U. and Grimm , E. A.Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin 2 in the generation of human lymphokine‐activated killer cell cytotoxicity . Cancer Res. , 48 , 788 – 792 ( 1988. ). [PubMed] [Google Scholar]
- 8. ) Lehmmann , V. , Benninghoff , B. and Droge , W.Tumor necrosis factor‐induced activation of peritoneal macro‐phages is regulated by prostaglandin E2 and cAMP . J. Immunol. , 141 , 587 – 591 ( 1988. ). [PubMed] [Google Scholar]
- 9. ) Shau , H.Characteristics and mechanism of neutrophil‐mediated cytostasis induced by tumor necrosis factor . J. Immunol. , 141 , 234 – 240 ( 1988. ). [PubMed] [Google Scholar]
- 10. ) Shalaby , M. R. , Espevik , T. , Rice , G. C. , Ammann , A. J. , Figari , I. S. , Ranges , G. E. and Palladino , M. A. , Jr.The involvement of human tumor necrosis factors‐a and ‐β in the mixed lymphocyte reaction . J. Immunol. , 141 , 499 – 503 ( 1988. ). [PubMed] [Google Scholar]
- 11. ) Ranges , G. E. , Zlotnik , A.Espevik , T. , Dinarello , C. A. , Cerami , A. and Palladino , M. A. , Jr.Tumor necrosis factor α/cachectin is a growth factor for thymocytes syn‐ergistic interactions with other cytokines . J. Exp. Med. , 167 , 1472 – 1478 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. ) Bussolino , F. , Camussi , G. and Baglioni , C.Synthesis and release of platelet‐activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin la . J. Biol. Cham. , 263 , 11856 – 11861 ( 1988. ). [PubMed] [Google Scholar]
- 13. ) Talmadge , J. E. , Phillips , H. , Schneider , M. , Rowe , T. , Pennington , R. , Bowersox , O. and Lenz , B.Immuno‐modulatory properties of recombinant murine and human tumor necrosis factor . Cancer Res. , 48 , 544 – 550 ( 1988. ). [PubMed] [Google Scholar]
- 14. ) Palladino , M. A. , Jr. , Shalaby , M. R. , Kramer , S. M. , Ferraiolo , B. L. , Baughman , R. A. , Deleo , A. B. , Crase , D. , Marafino , B. , Aggarwal , B. B. , Figari , I. S. , Liggitt , D. and Patton , J. S.Characterization of the antitumor activities of human tumor necrosis factor‐α and the com parison with other cytokines: induction of tumor‐specific immunity . J. Immunol. , 138 , 4023 – 4032 ( 1987. ). [PubMed] [Google Scholar]
- 15. ) Shimomura , K. , Manda , T. , Mukumoto , S. , Kobayashi , K. , Nakano , K. and Mori , J.Recombinant human tumor necrosis factor‐a: thrombus formation is a cause of anti‐tumor activity . Int. J. Cancer , 41 , 243 – 247 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Manda , T. , Nishigaki , F. , Mori , J. and Shimomura , K.Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor‐a in mice . Cancer Res. , 48 , 4250 – 4255 ( 1988. ). [PubMed] [Google Scholar]
- 17. ) Miyoshi , I. , Hiraki , S. , Tsubota , T. , Kubonishi , L , Matsuda , Y. , Nakayama , T. , Kishimoto , H. and Kimura , I.Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias . Nature , 267 , 843 – 844 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Nobuhara , M. , Kanamori , T. , Ashida , Y. , Ogino , H. , Horisawa , Y. , Nakayama , K. , Asami , T. , Iketani , M. , Noda , K. , Andoh , S. and Kurimoto , M.The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor . Jpn. J. Cancer Res. , 78 , 193 – 201 ( 1987. ). [PubMed] [Google Scholar]
- 19. ) Yamazaki , S. , Onishi , E. , Enami , K. , Natori , K. , Kohase , M. , Sakamoto , H. , Tanouchi , M. and Hayashi , H.Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor . Jpn. J. Med. Sci. Biol. , 39 , 105 – 118 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Sugarman , B. J. , Aggarwal , B. B. , Mass , P. E. , Figari , I. S. , Palladino , M. A. , Jr. and Shepard , H. M.Recombinant human tumor necrosis factor‐α: effects on proliferation of normal and transformed cells in vitro . Science , 230 , 943 – 945 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Tsujimoto , M. , Yip , Y. K. and Vilcek , J.Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells . Proc. NatL Acad. Sci. USA , 82 , 7626 – 7630 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. ) Creasey , A. A. , Yamamoto , R. and Vitt , C. R.A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity . Proc. Natl. Acad. Sci. USA , 84 , 3293 – 3297 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. ) Neale , M. L. , Fiera , R. A. and Matthews , N.Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor . Immunology , 64 , 81 – 85 ( 1988. ). [PMC free article] [PubMed] [Google Scholar]
- 24. ) Oi , V. T. , Glazer , A. N. and Stryer , L.Fluorescent phycobiliprotein conjugates for analyses of cells and molecules . J. Cell Biol. , 93 , 981 – 986 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
